Awarded contract

NHS National Framework Agreement for Omalizumab

Details

Buyer: NHS England
Supplier(s): Celltrion Healthcare United Kingdom Ltd, Mercury Pharmaceuticals Ltd, Novartis Pharmaceutical UK Ltd
Value: GBP 87,433,000
Duration: 2 years
Topic: Pharmaceutical products
Published: 28 November 2025
Source: uk:find_a_tender

Tender description

Project title: NHS National Framework for Omalizumab commencing 1st February 2026 Offer reference number: CM/TNS/25/5734 Period of framework: 1 February 2026 to 31 August 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England ## Contract award Title: Lot 1 - CM/TNS/25/5734 ## Contract award

Timeline

Completed: Award date26 November 2025
Completed: Award published28 November 2025
Current notice
Next: Contract expiry date31 August 2027in 12 months

About the buyer

NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

33600000 · Pharmaceutical products

Decision makers

Connect with the people behind this procurement.

Job title	Phone number	Work email
Head of Procurement	+44 •••• ••••••	••••••••@nhs-england.gov
Commercial Director	+44 •••• ••••••	••••••••@nhs-england.gov
Procurement Manager	+44 •••• ••••••	••••••••@nhs-england.gov
Category Lead	+44 •••• ••••••	••••••••@nhs-england.gov
Senior Buyer	+44 •••• ••••••	••••••••@nhs-england.gov
Contracts Manager	+44 •••• ••••••	••••••••@nhs-england.gov